Brad Fluegel was most recently the senior vice president - chief healthcare commercial market development officer for Walgreen Co., based in Deerfield, Ill. Previously, he was Chief Strategy and Business Development officer for Walgreens, responsible for corporate strategy and business development.
He joined Walgreens in October 2012 after previously serving as executive in residence at Health Evolution Partners. Before that he was executive vice president and chief strategy and external affairs officer of Wellpoint (now Anthem), among the nation’s largest health benefits companies.
Prior to Wellpoint, Brad was senior vice president of national accounts and vice president, enterprise strategy at Aetna, Inc. In this role, he led the national accounts business and was responsible for developing and executing on strategies that expanded Aetna’s position as a leader in the large employer market.
Earlier, Brad was CEO for Reden & Anders (Optum Consulting) and health sector leader at Tillinghast-Towers Perrin, a clinical, actuarial and management consulting practice that served all sectors of the health care industry.
Brad currently serves on the Board of Directors of Metropolitan Jewish Health System in New York City, Performant Financial Corporation, Premera Blue Cross, Alight Solutions, Itamar Medical and AdhereHealth. He also advises several health care companies and private equity firms. He served on the Fitbit Board of Directors until its sale to Google in early 2021.
Brad earned a master’s degree in public policy from Harvard University’s Kennedy School of Government and a bachelor of arts in business administration from the University of Washington.  He also serves as a lecturer at the University of Pennsylvania’s Wharton School of Business.